Germany Ready to Step On The Gas For Medtech But Reimbursement Delays Still Block The Road

After very complex national elections in 2017, Jens Spahn (CDU) emerged from the confusion holding the health portfolio. He is now ready to broach the trickier elements of his role, including finding solutions for the currently lengthy reimbursement delays for innovative medtech, which is a top priority for local manufacturers.

Car gas and brake pedals
Key Takeaways
  • German health-care policy backlog is now being tackled, with the new e-health law in preparation.

  • Industry might get more of a role on G-BA reimbursement committees – and attention to addressing current delays.

  • Early days still for Health Minister Jens Spahn, who is looking to accelerate policy efforts.

Structural improvements to Germany 's reimbursement evaluation process being pursued by Germany's current leadership, affirmed Karin Maag, who serves as lower house health

Maag set out the priorities and challenges for the government as it finally hits its stride during a political and regulatory updated hosted by BVMed, Germany's

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Germany

More from Europe